Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr 18;307(15):1580-2.
doi: 10.1001/jama.2012.489.

Use of administrative data to estimate the incidence of statin-related rhabdomyolysis

James S Floyd  1 , Susan R Heckbert, Noel S Weiss, David S Carrell, Bruce M Psaty
Affiliations

Use of administrative data to estimate the incidence of statin-related rhabdomyolysis

James S Floyd et al. JAMA. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

POTENTIAL FINANCIAL CONFLICTS OF INTEREST

No authors reported potential financial conflicts of interest.

References

    1. Staffa JA, Chang J, Green L. Cerivastatin and reports of fatal rhabdomyolysis. N Engl J Med. 2002 Feb 14;346(7):539–540. - PubMed
    1. Andrade SE, Graham DJ, Staffa JA, et al. Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis. J Clin Epidemiol. 2005 Feb;58(2):171–174. - PubMed
    1. Graham DJ, Staffa JA, Shatin D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. Jama. 2004 Dec 1;292(21):2585–2590. - PubMed
    1. Armitage J, Bowman L, Wallendszus K, et al. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. Lancet. 2010 Nov 13;376(9753):1658–1669. - PMC - PubMed
    1. Egan A, Colman E. Weighing the benefits of high-dose simvastatin against the risk of myopathy. N Engl J Med. 2011 Jul 28;365(4):285–287. - PubMed

Publication types

MeSH terms

Substances